ACE Inhibitors Lower Pneumonia Threat

APRIL 01, 2005

Patients who have had a stroke can ward off the risk of pneumonia with angiotensin-converting enzyme (ACE) inhibitors. For the study, the researchers evaluated the risk of pneumonia in >1000 patients who had had a stroke. The patients involved in the 35-month study were given 1 of 3 treatments: ACE inhibitors, other blood pressure drugs, or a placebo. The data showed 2.8% of the ACE inhibitor group developed pneumonia, compared with 8.5% of the patients in the other 2 groups. (The findings were reported in Neurology, February 9, 2005.)



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.